Ovarian cancer

You have access
Highly Aggressive Surgery Benefits in Patients With Advanced Ovarian Cancer
SHINICHI TATE, KYOKO NISHIKIMI, AYUMU MATSUOKA, SATOYO OTSUKA and MAKIO SHOZU

Anticancer Research July 2022, 42 (7) 3707-3716; DOI: https://doi.org/10.21873/anticanres.15860
You have access
Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients With Brain Metastasis from Ovarian Cancer
SHINICHI TATE, KYOKO NISHIKIMI, AYUMU MATSUOKA, SATOYO OTSUKA and MAKIO SHOZU

Anticancer Research May 2022, 42 (5) 2637-2644; DOI: https://doi.org/10.21873/anticanres.15741
Open Access
Biological Differences Between Ovarian Cancer-associated Fibroblasts and Contralateral Normal Ovary-derived Mesenchymal Stem Cells
KAZUAKI OHASHI, TAO-SHENG LI, SHOKO MIURA, YURI HASEGAWA and KIYONORI MIURA

Anticancer Research April 2022, 42 (4) 1729-1737; DOI: https://doi.org/10.21873/anticanres.15649
You have access
Lactate Is a Reliable Predictor of ICU Length of Stay Following Ultra-radical Ovarian Cancer Surgery
SUSAN ADDLEY, MARK MCGOWAN, VIREN ASHER, ANISH BALI, SUMMI ABDUL, VICTORIA CULLIMORE, HARRIET CROSSLAND and ANDREW PHILLIPS

Anticancer Research April 2022, 42 (4) 1979-1986; DOI: https://doi.org/10.21873/anticanres.15676
You have access
Investigation of Hypersensitivity Reactions in Carboplatin Desensitization Therapy
NAOKI SHIBATA, KAZUYOSHI KAWAKAMI, SHIMIZU HISANORI, KAZUO KOBAYASHI, MAYU YUNOKAWA, HIROYUKI KANAO, IORI TAKI, REMI MURASE, DAISUKE KAMEI and MASAKAZU YAMAGUCHI

Anticancer Research February 2022, 42 (2) 1091-1097; DOI: https://doi.org/10.21873/anticanres.15571
You have access
Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Ovarian Cancer Treated With Primary Surgery Followed by Platinum-based Chemotherapy: A Single-center Italian Study
ANGIOLO GADDUCCI, ENRICO SIMONETTI, FRANCESCO MEZZAPESA, STEFANIA COSIO, MARIO MICCOLI, JESSICA FREY, RACHELE TINTORI, ALESSANDRA BULLERI and EMANUELE NERI

Anticancer Research February 2022, 42 (2) 947-954; DOI: https://doi.org/10.21873/anticanres.15554
You have access
Circulating Markers of Neutrophil Extracellular Traps (NETs) in Patients With Ovarian Tumors
ARTURAS DOBILAS, CHARLOTTE THALIN, HAKAN WALLEN and CHRISTER BORGFELDT

Anticancer Research February 2022, 42 (2) 965-971; DOI: https://doi.org/10.21873/anticanres.15556
You have access
Correlation Between Clinical Outcomes and Serum CA-125 Levels After Standard Treatment for Epithelial Ovarian Cancer
JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG

Anticancer Research January 2022, 42 (1) 349-353; DOI: https://doi.org/10.21873/anticanres.15492
You have access
Prospects of Improving Early Ovarian Cancer Diagnosis Using Cervical Cell Swabs
EDYTA BISKUP, REGITZE SOLLING WILS, CLAUS HOGDALL and ESTRID HOGDALL

Anticancer Research January 2022, 42 (1) 1-12; DOI: https://doi.org/10.21873/anticanres.15451
You have access
Applicability of the Histoculture Drug Response Assay to Predict Platinum Sensitivity and Prognosis in Ovarian Cancer
JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG

Anticancer Research December 2021, 41 (12) 6287-6292; DOI: https://doi.org/10.21873/anticanres.15450

Main menu

User menu

Search

Ovarian cancer

Pages